Markus Lundgren
11 – 20 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
(
- Contribution to journal › Article
- 2023
-
Mark
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance : the TEDDY study
(
- Contribution to journal › Article
-
Mark
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
(
- Contribution to journal › Article
- 2022
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
(
- Contribution to journal › Article
-
Mark
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies
(
- Contribution to journal › Article
-
Mark
Is staff consistency important to parents' satisfaction in a longitudinal study of children at risk for type 1 diabetes : the TEDDY study
(
- Contribution to journal › Article
-
Mark
Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease
(
- Contribution to journal › Article